Severe acute respiratory syndrome coronavirus-2-related and imputable deaths in children: results from the French pediatric national registry.
Death
Pediatric intensive care unit
SARS-CoV-2
Journal
World journal of pediatrics : WJP
ISSN: 1867-0687
Titre abrégé: World J Pediatr
Pays: Switzerland
ID NLM: 101278599
Informations de publication
Date de publication:
20 Mar 2024
20 Mar 2024
Historique:
received:
14
08
2023
accepted:
14
12
2023
medline:
20
3
2024
pubmed:
20
3
2024
entrez:
20
3
2024
Statut:
aheadofprint
Résumé
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for an important mortality rate worldwide. We aimed to evaluate the actual imputability of SARS-CoV-2 on the mortality rate associated with SARS-CoV-2-related illnesses in the pediatric intensive care unit (PICU). Secondary objectives were to identify risk factors for death. This national multicenter comparative study comprised all patients under 18 years old with positive SARS-CoV-2 polymerase chain reactions (PCRs) [acute corona virus disease 2019 (COVID-19) or incidental SARS-CoV-2 infection] and/or pediatric inflammatory multisystem syndrome (PIMS) recorded in the French PICU registry (PICURe) between September 1, 2021, and August 31, 2022. Included patients were classified and compared according to their living status at the end of their PICU stay. Deceased patients were evaluated by four experts in the field of pediatric infectiology and/or pediatric intensive care. The imputability of SARS-CoV-2 as the cause of death was classified into four categories: certain, very probable, possible, or unlikely, and was defined by any of the first three categories. There were 948 patients included of which 43 died (4.5%). From this, 26 deaths (67%) could be attributed to SARS-CoV-2 infection, with an overall mortality rate of 2.8%. The imputability of death to SARS-CoV-2 was considered certain in only one case (0.1%). Deceased patients suffered more often from comorbidities, especially heart disease, neurological disorders, hematological disease, cancer, and obesity. None of the deceased patients were admitted for pediatric inflammatory multisystem syndrome (PIMS). Mortality risk factors were male gender, cardiac comorbidities, cancer, and acute respiratory distress syndrome. SARS-CoV-2 mortality in the French pediatric population was low. Even though the imputability of SARS-CoV-2 on mortality was considered in almost two-thirds of cases, this imputability was considered certain in only one case.
Sections du résumé
BACKGROUND
BACKGROUND
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for an important mortality rate worldwide. We aimed to evaluate the actual imputability of SARS-CoV-2 on the mortality rate associated with SARS-CoV-2-related illnesses in the pediatric intensive care unit (PICU). Secondary objectives were to identify risk factors for death.
METHODS
METHODS
This national multicenter comparative study comprised all patients under 18 years old with positive SARS-CoV-2 polymerase chain reactions (PCRs) [acute corona virus disease 2019 (COVID-19) or incidental SARS-CoV-2 infection] and/or pediatric inflammatory multisystem syndrome (PIMS) recorded in the French PICU registry (PICURe) between September 1, 2021, and August 31, 2022. Included patients were classified and compared according to their living status at the end of their PICU stay. Deceased patients were evaluated by four experts in the field of pediatric infectiology and/or pediatric intensive care. The imputability of SARS-CoV-2 as the cause of death was classified into four categories: certain, very probable, possible, or unlikely, and was defined by any of the first three categories.
RESULTS
RESULTS
There were 948 patients included of which 43 died (4.5%). From this, 26 deaths (67%) could be attributed to SARS-CoV-2 infection, with an overall mortality rate of 2.8%. The imputability of death to SARS-CoV-2 was considered certain in only one case (0.1%). Deceased patients suffered more often from comorbidities, especially heart disease, neurological disorders, hematological disease, cancer, and obesity. None of the deceased patients were admitted for pediatric inflammatory multisystem syndrome (PIMS). Mortality risk factors were male gender, cardiac comorbidities, cancer, and acute respiratory distress syndrome.
CONCLUSIONS
CONCLUSIONS
SARS-CoV-2 mortality in the French pediatric population was low. Even though the imputability of SARS-CoV-2 on mortality was considered in almost two-thirds of cases, this imputability was considered certain in only one case.
Identifiants
pubmed: 38506979
doi: 10.1007/s12519-023-00791-x
pii: 10.1007/s12519-023-00791-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Children's Hospital, Zhejiang University School of Medicine.
Références
Salzberger B, Buder F, Lampl B, Ehrenstein B, Hitzenbichler F, Holzmann T, et al. Epidemiology of SARS-CoV-2. Infection. 2021;49:233–9.
doi: 10.1007/s15010-020-01531-3
pubmed: 33034020
COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21. Lancet. 2022;399:1513–6.
Marwali EM, Kekalih A, Yuliarto S, Wati DK, Rayhan M, Valerie IC, et al. Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity. BMJ Paediatr Open. 2022;6:e001657.
doi: 10.1136/bmjpo-2022-001657
pubmed: 36645791
pmcid: 9621167
Nachega JB, Sam-Agudu NA, Budhram S, Taha TE, Vannevel V, Somapillay P, et al. Effect of SARS-CoV-2 Infection in pregnancy on maternal and neonatal outcomes in Africa: an AFREhealth call for evidence through multicountry research collaboration. Am J Trop Med Hyg. 2020;104:461–5.
pubmed: 33372651
pmcid: 7866362
Liguoro I, Pilotto C, Bonanni M, Ferrari ME, Pusiol A, Nocerino A, et al. SARS-COV-2 infection in children and newborns: a systematic review. Eur J Pediatr. 2020;179:1029–46.
doi: 10.1007/s00431-020-03684-7
pubmed: 32424745
pmcid: 7234446
Tsankov BK, Allaire JM, Irvine MA, Lopez AA, Sauvé LJ, Vallance BA, et al. Severe COVID-19 infection and pediatric comorbidities: a systematic review and meta-analysis. Int J Infect Dis. 2021;103:246–56.
doi: 10.1016/j.ijid.2020.11.163
pubmed: 33227520
Harman K, Verma A, Cook J, Radia T, Zuckerman M, Deep A, et al. Ethnicity and COVID-19 in children with comorbidities. The Lancet Child Adolesc Health. 2020;4:e24–5.
doi: 10.1016/S2352-4642(20)30167-X
pubmed: 32473663
Bixler D, Miller AD, Mattison CP, Taylor B, Komatsu K, Peterson Pompa X, et al. SARS-CoV-2–associated deaths among persons aged 21 years—United States. MMWR Morb Mortal Wkly Rep. 2020;69:1324–9.
doi: 10.15585/mmwr.mm6937e4
pubmed: 32941417
Alsohime F, Temsah MH, Al-Nemri AM, Somily AM, Al-Subaie S. COVID-19 infection prevalence in pediatric population: etiology, clinical presentation, and outcome. J Infect Public Health. 2020;13:1791–6.
doi: 10.1016/j.jiph.2020.10.008
pubmed: 33127335
pmcid: 7574780
World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19. https://www.who.int/publications-detail-redirect/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19 . Accessed 20 June 2023.
Recher M, Leteurtre S, Javouhey E, Morin L, Baudin F, Rambaud J, et al. Risk of admission to the pediatric intensive care unit for SARS-CoV-2 delta and omicron infections. J Pediatric Infect Dis Soc. 2023;12:189–97.
doi: 10.1093/jpids/piad010
pubmed: 36786499
Burns KE, Duffett M, Kho ME, Meade MO, Adhikari NK, Sinuff T, et al. A guide for the design and conduct of self-administered surveys of clinicians. CMAJ. 2008;179:245–52.
doi: 10.1503/cmaj.080372
pubmed: 18663204
pmcid: 2474876
Lecoeur C, Thibon P, Prime L, Mercier PY, Balouet P, Durin L, et al. Frequency, causes and avoidability of outborn births in a French regional perinatal network. Eur J Obstet Gynecol Reprod Biol. 2014;179:22–6.
doi: 10.1016/j.ejogrb.2014.05.009
pubmed: 24965974
Martinet Y. Expertise médicale en pneumologie; question de l’imputabilité du décès. Rev Mal Respir. 2011;28:594–601 (in French).
doi: 10.1016/j.rmr.2011.01.007
pubmed: 21645829
Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021;21:855.
doi: 10.1186/s12879-021-06536-3
pubmed: 34418980
pmcid: 8380115
Manti S, Licari A, Montagna L, Votto M, Leonardi S, Brambilla I, et al. SARS-CoV-2 infection in pediatric population. Acta Biomed. 2020;91(Suppl 11): e2020003.
pubmed: 33004773
pmcid: 8023063
CDC COVID-19 Response Team. Coronavirus Disease. in Children — United States, February 12–April 2, 2020. MMWR Morb Mortal Wkly Rep. 2019;2020(69):422–6.
Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020;39:355–68.
doi: 10.1097/INF.0000000000002660
pubmed: 32310621
pmcid: 7158880
European Centre for Disease Prevention and Control. COVID-19. https://www.ecdc.europa.eu/en/covid-19 . Accessed July 5, 2023.
Mehta NS, Mytton OT, Mullins EWS, Fowler TA, Falconer CL, Murphy OB, et al. SARS-CoV-2 (COVID-19): What do we know about children? a systematic review. Clin Infect Dis. 2020;71:2469–79.
doi: 10.1093/cid/ciaa556
pubmed: 32392337
pmcid: 7239259
Rodriguez Velásquez S, Jacques L, Dalal J, Sestito P, Habibi Z, Venkatasubramanian A, et al. The toll of COVID-19 on African children: a descriptive analysis on COVID-19-related morbidity and mortality among the pediatric population in Sub-Saharan Africa. Int J Infect Dis. 2021;110:457–65.
doi: 10.1016/j.ijid.2021.07.060
pubmed: 34332088
pmcid: 8457828
van der Zalm MM, Dona’ D, Rabie H. Pediatric coronavirus disease 2019 in Africa. Curr Opin Pediatr. 2023;35:176–83.
doi: 10.1097/MOP.0000000000001230
pubmed: 36806080
pmcid: 9994569
Nachega JB, Sam-Agudu NA, Machekano RN, Rabie H, van der Zalm MM, Redfern A, et al. African Forum for Research and Education in Health (AFREhealth) COVID-19 Research Collaboration on Children and Adolescents. Assessment of clinical outcomes among children and adolescents hospitalized with COVID-19 in 6 sub-Saharan African countries. JAMA Pediatr. 2022;176:e216436.
doi: 10.1001/jamapediatrics.2021.6436
pubmed: 35044430
pmcid: 8771438
Mosalli RM, Kobeisy SAN, Al-Dajani NM, Ateeg MA, Ahmed MA, Meer WM, et al. Coronavirus disease in children: a single-center study from western Saudi Arabia. Int J Pediatr. 2021;2021:9918056.
doi: 10.1155/2021/9918056
pubmed: 34394360
pmcid: 8360710
Alshengeti A, Alahmadi H, Barnawi A, Alfuraydi N, Alawfi A, Al-Ahmadi A, et al. Epidemiology, clinical features, and outcomes of coronavirus disease among children in Al-Madinah, Saudi Arabia: a retrospective study. Int J Pediatr Adolesc Med. 2022;9:136–42.
doi: 10.1016/j.ijpam.2021.11.001
pubmed: 35663790
Kitano T, Kitano M, Krueger C, Jamal H, Al Rawahi H, Lee-Krueger R, et al. The differential impact of pediatric COVID-19 between high-income countries and low- and middle-income countries: a systematic review of fatality and ICU admission in children worldwide. PLoS One. 2021;16:e0246326.
doi: 10.1371/journal.pone.0246326
pubmed: 33513204
pmcid: 7845974
Heneghan JA, Rogerson C, Goodman DM, Hall M, Kohne JG, Kane JM. Epidemiology of pediatric critical care admissions in 43 united states children’s hospitals, 2014–2019. Pediatr Crit Care Med. 2022;23:484–92.
doi: 10.1097/PCC.0000000000002956
pubmed: 35435887
PICANet – Paediatric Intensive Care Audit Network for the UK and Ireland. Annual Report 2021. https://www.picanet.org.uk/wp-content/uploads/sites/25/2022/04/PICANet-2021-Annual-Report_v1.1-22Apr2022.pdf . Accessed 3 May 2023.
COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med. 2021;47:60–73.
Shapira G, de Walque D, Friedman J. How many infants may have died in low-income and middle-income countries in 2020 due to the economic contraction accompanying the COVID-19 pandemic? Mortality projections based on forecasted declines in economic growth. BMJ Open. 2021;11:e050551.
doi: 10.1136/bmjopen-2021-050551
pubmed: 34429282
Coker M, Folayan MO, Michelow IC, Oladokun RE, Torbunde N, Sam-Agudu NA. Things must not fall apart: the ripple effects of the COVID-19 pandemic on children in sub-Saharan Africa. Pediatr Res. 2021;89:1078–86.
doi: 10.1038/s41390-020-01174-y
pubmed: 32971527
Flood J, Shingleton J, Bennett E, Walker B, Amin-Chowdhury Z, Oligbu G, et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): prospective, national surveillance, United Kingdom and Ireland, 2020. Lancet Reg Health Eur. 2021;3:100075.
doi: 10.1016/j.lanepe.2021.100075
pubmed: 34027512
pmcid: 8132575
Bowen A, Miller AD, Zambrano LD, Wu MJ, Oster ME, Godfred-Cato S, et al. Demographic and clinical factors associated with death among persons <21 years old with multisystem inflammatory syndrome in children—United States, February 2020–March 2021. Open Forum Infect Dis. 2021;8:ofab388.
Abdel-Mannan O, Sutcliffe AG. A national surveillance study of childhood epilepsy mortality in the UK and Ireland. Eur J Neurol. 2020;27:327–33.
doi: 10.1111/ene.14081
pubmed: 31502743
Swann OV, Holden KA, Turtle L, Pollock L, Fairfield CJ, Drake TM, et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ. 2020;370:m3249.
doi: 10.1136/bmj.m3249
pubmed: 32960186